Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Winthrop Products is a pharmaceutical company that currently operates as a subsidiary of Sanofi, primarily serving as a brand for its generic drug portfolio in various international markets. Originally established as the international arm of the Winthrop Chemical Company and Sterling Drug, the entity has a legacy spanning over a century in the development and distribution of essential medicines. Following the 1994 acquisition of Sterling Winthrop's prescription business by Sanofi, the Winthrop name was integrated into Sanofi's global operations to manage off-patent products. The company's offerings include a wide array of small molecule therapies targeting indications in pain management, cardiology, and infectious diseases. Today, Winthrop Products remains a key component of Sanofi's strategy to provide affordable, high-quality healthcare solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Winthrop Products.